Viatris announced the appointment of Tayga Kaan Hilal as Country Manager in Türkiye. Tayga Kaan Hilal will manage Viatris’ commercial operations in Türkiye in his new role.
Kaan Hilal, who has previously worked in key leadership roles in the field of business and treatment in many geographies, has a wealth of experience as a senior executive in the pharmaceutical industry. In his most recent role as Head of Sales Excellence and Commercial Capabilities, Kaan Hilal managed Viatris’ Sales Excellence, Talent Development and Training Organization in Emerging Markets.
During his career of more than 13 years, Kaan Hilal has played key roles in Sales and Marketing, Sales Force Effectiveness and Business Development at Pfizer Türkiye. Kaan Hilal previously led Business Operations and Corporate Analytics for Russia, Türkiye, Africa and the Middle East at Pfizer.
Viatris Türkiye
Viatris’ local footprint in Türkiye includes a workforce of more than 500 and a manufacturing facility that produces high-quality medicines for Viatris’ portfolios in Cardiology, Urology, Pain and Mental Health. In addition, Viatris Türkiye is part of Viatris, a global pharmaceutical company that bridges the gap between generic drugs and brands. Viatris and Viatris Türkiye are described as a pharmaceutical company uniquely positioned to fulfill its mission of empowering people all over the world to live healthier lives at every stage of life, regardless of geography or conditions.
Viatris carries out its activities in Türkiye under two separate companies: Meda Pharma İlaç San. ve Tic. Ltd. Şti and Pfizer İlaçları Ltd. Şti (subsidiary of Viatris Inc.)
